Delivery of cell cycle genes to block astrocytoma growth
J Fueyo1, C Gomez-Manzano, T J Liu
1Department of Neuro-Oncology, University of Texas M.D. Anderson Cancer Center, Houston 77030, USA.
Abstract:
Current therapies for glioblastoma multiforme are ineffective. Therefore, novel therapies that target specific differences between normal and malignant cells are urgently needed. Abnormalities of cell-cycle related genes are a common feature of cancer in general and astrocytic tumors in particular. The role of these proteins is to help to regulate cell proliferation, differentiation and apoptosis. Restoring wild-type activity of critical regulators of the cell cycle to astrocytic tumors generally results in modification of the growth properties, and often the viability, of the cancer cells. Transfer of p53 induces growth arrest and, more importantly, apoptosis. Restoration of the Rb pathway results in either reversible growth arrest or senescence. Expression of E2F-1 induces transient increase of proliferation followed by massive apoptosis. Overexpression of MMAC/PTEN arrests cell cycle progression in G1 and promotes anoikis. Current knowledge of the functions of these cell-cycle controllers can be used to design small peptides and drugs to induce cell-cycle related anti-cancer effect. Inactivation of the p53 and Rb pathways in cancer cells is also being used to engineer mutant viruses that are able to replicate exclusively in cancer cells.
Insights
Novel therapies targeting cell-cycle gene abnormalities are needed for glioblastoma multiforme. Restoring wild-type gene activity, like p53 and Rb, shows promise in halting cancer cell growth and inducing apoptosis.
Area of Science:
- Oncology
- Molecular Biology
- Cancer Genetics
Background:
- Glioblastoma multiforme (GBM) therapies are currently ineffective, necessitating novel treatment strategies.
- Abnormalities in cell-cycle related genes are prevalent in cancers, particularly astrocytic tumors.
- Understanding the regulatory roles of cell-cycle proteins in proliferation, differentiation, and apoptosis is crucial.
Purpose of the Study:
- To explore novel therapeutic strategies for glioblastoma multiforme by targeting cancer-specific cellular differences.
- To investigate the potential of restoring wild-type activity of cell-cycle regulators in astrocytic tumors.
- To leverage knowledge of cell-cycle controllers for designing targeted anti-cancer agents and therapies.
Main Methods:
- Investigating the effects of restoring wild-type p53, Rb pathway, E2F-1, and MMAC/PTEN in astrocytic tumors.
- Analyzing the impact of these genetic restorations on cell proliferation, differentiation, apoptosis, and cell-cycle progression.
- Exploring the engineering of mutant viruses that selectively replicate in cancer cells by exploiting p53 and Rb pathway inactivation.
Main Results:
- Restoration of p53 induces growth arrest and apoptosis in cancer cells.
- Restoration of the Rb pathway leads to reversible growth arrest or senescence.
- Overexpression of MMAC/PTEN arrests cell cycle progression and promotes anoikis, while E2F-1 expression causes transient proliferation followed by apoptosis.
Conclusions:
- Targeting cell-cycle regulators offers a promising avenue for novel glioblastoma multiforme therapies.
- The design of small peptides and drugs based on cell-cycle controller functions can induce anti-cancer effects.
- Exploiting cancer-specific genetic alterations, such as p53 and Rb pathway inactivation, enables the development of targeted oncolytic viruses.
Related Concept Videos
02:34Inhibition of Cdk Activity
01:05Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
01:20The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
02:34Inhibition of CDK Activity